The US Gene Therapy Market trends reveal a shift toward personalized medicine, targeted gene editing, and digital integration to improve patient outcomes. Increasing adoption of CRISPR-based therapies, viral and non-viral vectors, and RNA-based interventions are driving innovation in the field. Patients and clinicians are prioritizing treatments that allow precision targeting of disease-causing...
The management of Thalassemia in India is undergoing a profound transformation, moving from reliance on decades-old supportive care methods to the introduction of revolutionary, curative therapies. Historically, the **India Thalassemia Market** has been defined by two pillars of treatment: regular, life-saving blood transfusions to manage chronic anemia and iron chelation therapy to combat the...
Market Overview
The global viral vector manufacturing market size was valued at USD 267.8 million in 2024 and is expected to grow from USD 336.36 million in 2025 to USD 3189.15 million by 2033, growing at a CAGR of 19.7% during the forecast period (2025-2033). The growth of the market is attributed to growth in the genetic disorder.
The global Viral...
فارسی
English
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Arabic